News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
USDA Will Not Regulate CRISPR-Edited Crops
Diana Kwon | Apr 2, 2018
Restrictions will remain on transgenic plants, which contain artificially inserted genes from other species.
Scientists Reverse Their Controversial Findings of CRISPR's Off-Target Effects
Diana Kwon | Mar 28, 2018
Last year, researchers claimed the gene-editing method had accuracy issues, but a new whole-genome sequencing analysis by the same team finds otherwise.
Berkeley CRISPR Inventors Get Another Important European Patent
Jim Daley | Mar 12, 2018
This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.
Image of the Day: Glowing Larva
Staff, The Scientist Staff | Mar 9, 2018
Researchers identified a gene in mosquitoes that moderates their susceptibility to malaria parasite infection.
New Enzyme Makes CRISPR More Powerful
Shawna Williams | Mar 2, 2018
xCas9 enables more precisely targeted gene editing.
New Methods to Detect CRISPR Off-Target Mutations
Sandeep Ravindran | Mar 1, 2018
Researchers have developed a variety of techniques to detect when CRISPR misses the mark.
New CRISPR-Based Tools Flag Genetic Sequences and Log Data
Diana Kwon | Feb 16, 2018
SHERLOCK and DETECTR can identify particular nucleic acid sequences, while CAMERA records events in human and bacterial cells.
Stem Cells Made by Modifying the Epigenome with CRISPR
Abby Olena | Jan 25, 2018
Researchers use the technique to turn on
in mouse embryonic fibroblasts and convert them into pluripotent cells.
Researchers Discover 10 New Immune Systems in Bacteria
Jim Daley | Jan 25, 2018
The findings more than double the number of known defense mechanisms, piquing the interests of molecular biology tool developers.
Immunity May Make CRISPR-Based Therapies Ineffective
Jim Daley | Jan 10, 2018
Researchers identify antibodies for two commonly used Cas9 proteins in human blood. Investors take notice.